3Chen TM, Li FK, Tang CSO,et al. Efficacy of mucophenolate mofetil in patients with diffuse proliferative lupus nephritis. New Engl J Med, 2000, 343 (16): 1156.
4Briggs WA, Choi M J, Scheel PJ. Fellow-up on mycophenolate treatment of glomerular disease. Am J Kidney Dis, 1998, 32: 898.
5Miller G, Zimmerman RM, Radhakrishnan J. Use of mycophenolate9mofetil in resistant membranous nephropathy. Am J Kidney Dis, 2000, 36 (2): 250.
6Wang HY, et al. Mycophenolate mofetil (MMF) is an effective immunosuppressive agent for patients with refractorynephrotic syndrome. J Am Soc Nephrol, 2000, 11: 101A.
7Nowack R, Gobel U, Klooker P, et al. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am SocNephrol, 1999, 10: 1965.
4Ando K, Suzuki S, Tarnura G, et al. Antiviral activity of mycophenolic acid. Studies on antiviral and antitumor antibiotics. IV [J]. J. Antibiotics (Tokyo), 1968, 21( 11 ) : 649-652.
5Noto T, Sawada M, Ando M, et al.Some biological properties of mycophenolic acid [J].J Antibiotics (Tokyo), 1969, 22(4) : 165 - 169.
6Ohsugi Y, Suzuki S, Takagaki Y.Antitumor and immunosuppressive effects of mycophenolic acid derivatives [J].Cancer Res, 1976, 36 ( 8 ) : 2923-2927.
8W. L. Muth & C.H. Nash III. Biosynthesis of mycophenolic acid: purification and characterization of S-adanosyl-L-methionine: demethylmycophenolic acid O-methyhransferase [J].Antimicrobial Agents and Chemotherapy, 1975, Sep, 8(3) :321-327.
